# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-24-070450
Filing Date
2024-06-11
Accepted
2024-06-11 17:00:39
Documents
31
Period of Report
2024-06-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2416963d1_8k.htm iXBRL | 8-K | 26020
2 | EXHIBIT 99.1 | tm2416963d1_ex99-1.htm | EX-99.1 | 27398
3 | EXHIBIT 99.2 | tm2416963d1_ex99-2.htm | EX-99.2 | 15332
7 | GRAPHIC | tm2416963d1_ex99-1img001.jpg | GRAPHIC | 24933
8 | GRAPHIC | tm2416963d1_ex99-2img001.jpg | GRAPHIC | 277618
9 | GRAPHIC | tm2416963d1_ex99-2img002.jpg | GRAPHIC | 336633
10 | GRAPHIC | tm2416963d1_ex99-2img003.jpg | GRAPHIC | 177240
11 | GRAPHIC | tm2416963d1_ex99-2img004.jpg | GRAPHIC | 277352
12 | GRAPHIC | tm2416963d1_ex99-2img005.jpg | GRAPHIC | 291399
13 | GRAPHIC | tm2416963d1_ex99-2img006.jpg | GRAPHIC | 230230
14 | GRAPHIC | tm2416963d1_ex99-2img007.jpg | GRAPHIC | 225512
15 | GRAPHIC | tm2416963d1_ex99-2img008.jpg | GRAPHIC | 225226
16 | GRAPHIC | tm2416963d1_ex99-2img009.jpg | GRAPHIC | 255742
17 | GRAPHIC | tm2416963d1_ex99-2img010.jpg | GRAPHIC | 328872
18 | GRAPHIC | tm2416963d1_ex99-2img011.jpg | GRAPHIC | 394683
19 | GRAPHIC | tm2416963d1_ex99-2img012.jpg | GRAPHIC | 260285
20 | GRAPHIC | tm2416963d1_ex99-2img013.jpg | GRAPHIC | 234991
21 | GRAPHIC | tm2416963d1_ex99-2img014.jpg | GRAPHIC | 286475
22 | GRAPHIC | tm2416963d1_ex99-2img015.jpg | GRAPHIC | 298228
| Complete submission text file | 0001104659-24-070450.txt |  | 5940009

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | anvs-20240611.xsd | EX-101.SCH | 3021
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | anvs-20240611_lab.xml | EX-101.LAB | 34240
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | anvs-20240611_pre.xml | EX-101.PRE | 22363
34 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2416963d1_8k_htm.xml | XML | 3791

Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39202 | Film No.: 241036573
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)